These portraits from artists around the world made me feel seen.
Lufthansa is adding more holiday destinations to its summer flight schedule from Germany in anticipation of a strong rebound in bookings, it said on Thursday, betting COVID-19 vaccines and testing will soon make vacation travel possible. Germany's largest airline said it was planning to add around 20 new destinations from Frankfurt and 13 from Munich to locations such as the Caribbean, the Canary Islands and Greece. "We expect many countries to relax travel restrictions towards the summer as more and more people have been vaccinated," Lufthansa board member Harry Hohmeister said in a statement.
Gary Walker, 57, killed Caroline Walker, 50, and Katie Walker, 24, at their family home in Hemel Hempstead, Hertfordshire, then set himself and the house on fire in March 2020.
Beeple is selling these works as NFTs — nonfungible tokens — digital collectibles that use blockchain technology as authentication.
The involvement of women like Santosh Sandhu, particularly from the state of Haryana, which is not known for being progressive, is noteworthy, especially given that they're tending to households as well as farmlands.
Jacob Tremblay, Jack Dylan Grazer, Emma Berman, Maya Rudolph, Marco Barricelli and Jim Gaffigan will be featured in the voice cast of the upcoming Disney-Pixar animated feature film Luca. The cast, along with a teaser trailer and poster, was unveiled today. Watch the teaser above, and see additional photos below. Disney and Pixar describe Luca […]
Before COVID-19, visits to Greece's paper-strewn labour offices were a ordeal of queues and case files, often for basic matters that in less than a year have moved online as the pandemic upended old administrative routines. "Essentially overnight, two thirds of the visits were no longer necessary," said Spiros Protopsaltis, head of OAED, the Organization of Employment and Unemployment Insurance. Crammed with thousands of folders and blue OAED registration cards spilling out onto desks and floor space, the corridors of the building where he spoke still offer a daunting vision of the challenge to overhauling public services in Greece.
Spinner Axar Patel took five for 32 to finish with a match haul of 11 wickets.
New Research from the Center for State and Local Government Excellence at ICMA-RC Examines K-12 Employee Sentiment on Key Job Issues Since Onset of PandemicWashington, D.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- A nationwide poll of K-12 employees finds this segment of the state and local workforce has heightened concerns stemming from the COVID-19 pandemic. Of those surveyed, the vast majority reported feeling stressed (63%), high levels of burnout/fatigue (54%), and substantial anxiety (47%) at work due to the pandemic. These worries come as K-12 employees were significantly more likely than other government employees to perceive themselves to be at risk of exposure to COVID-19 at work (60% vs. 38%). K-12 employees’ general satisfaction with their employers plummeted from 69% in March 2020, to 44% in October 2020. Additionally, more public education professionals could leave their jobs at a time when many state and local governments are struggling to recruit and retain teachers. More than one-third (38%) of K-12 employees say that working during the pandemic has made them consider changing jobs, as compared to 25% of other government employees. These findings are contained in a new report from the Center for State and Local Government Excellence at ICMA-RC (SLGE at ICMA-RC), K-12 Public School Employee Views on Finances, Employment Outlook, and Safety Concerns Due to COVID-19. Download the report. In addition to describing the results of the survey, the report offers recommendations for states and localities to think strategically to address these challenges. To help alleviate the safety, health, job, and financial concerns of K-12 employees, the report highlights four areas of focus for state and local governments: financial wellness, employee morale, remote work and nontraditional benefits. A webinar is scheduled for Thursday, March 4, 2021, at 1:00 p.m. ET. Register for the webinar. “These findings should ring the alarm bell for policymakers grappling with the short- and long-term impacts of the COVID-19 pandemic on the U.S. education system and the K-12 workforce,” said Rivka Liss-Levinson, Ph.D., Senior Research Manager at SLGE at ICMA-RC. “State and local lawmakers are tackling complicated issues – coping with remote learning, vaccinating teachers, transitioning children back to schools, addressing school budget and teacher compensation, and filling staff shortages. We hope these findings will help inform public policy decisions on critical issues that impact K-12 workers, children and families,” she said. “Educators are central to student achievement, just as high quality education is essential for U.S. economic competitiveness; and left unaddressed, the harm to the U.S. education workforce could be deep,” said Orlando Cruz, Senior Vice President at ICMA-RC. “This research tells us that the pandemic has placed a heavy burden on the K-12 public school workforce. It is more important than ever to engage our participants with educational tools, guidance, and resources that not only help alleviate the anxiety levels faced by educators today, but also help set them up for future financial success beyond the pandemic.” The report finds: There has been a sharp decline in education employees’ job satisfaction since the onset of the pandemic. K-12 employees’ general satisfaction with their employer fell from 69% in March 2020, to 44% in October 2020. Work hours have increased substantially in the wake of the pandemic. Of K-12 employees, 41% reported that they are working more hours (either officially or unofficially) in October 2020 than they were prior to the pandemic. This is most often due to the extra work that online/remote work entails (78%), an increased number of parent or student meetings/communications (52%), and an increased number of work meetings/communications (50%).The nature of work in education has changed dramatically due to COVID-19, more so than for other state and local employees, and the adjustment has been difficult. In October 2020, 55% of K-12 employees and 35% of other government employees reported that the pandemic has significantly impacted the nature of their job. While 46% of K-12 employees rated the adjustment as extremely or very difficult, fewer than half as many other government employees did (22%).K-12 workers are more likely than other state and local employees to be considering changing jobs and to believe the job risks are not on par with their compensation. While 55% of K-12 employees reported that the risks they are taking during the pandemic are not on par with their compensation, only 44% of other government employees did. Further, 38% of K-12 employees say that working during the pandemic has made them consider changing jobs, as compared to 25% of other government employees.Public school employees were significantly more likely than other government workers to report feeling stressed and/or burned out/fatigued. K-12 employees most often reported feeling stressed (63%), burned out/fatigued (54%), and/or anxious (47%) at work due to the pandemic. For other state and local employees, these rates were lower – 52% for stress, 47% for burnout/fatigue, and 44% for anxiety at work. K-12 employees were significantly more likely to perceive themselves to be at risk of exposure to COVID-19 at work than other government employees. Of K-12 employees, 60% felt that they are at very or extremely high risk, as compared to 38% of other government employees.K-12 employees worry about keeping their family safe from contracting COVID-19, about contracting the virus at work, and having their employee benefits package reduced. They were more likely than other government employees to be very or extremely concerned about most issues, especially keeping their family safe from contracting the virus (61% versus 48%), and staying protected from contracting the virus at work (61% versus 43%).More are juggling childcare while working as compared to their state and local employee counterparts. While 60% of K-12 employees who are parents of children under the age of 18 have had to work from home while taking care of their kids for a lengthy period of time, fewer than 40% of other government employees have had to do so.More K-12 workers say the pandemic has harmed their family finances than other public employees. Among K-12 survey respondents, 60% reported that they and their family have been negatively impacted financially by the pandemic, while half of other government employees did. K-12 employees are increasingly worried about retirement. Of state and local education staff, 48% are concerned about their ability to save enough to be financially secure throughout retirement. This level of concern is at 39% for other public employees. In October 2020, 45% of K-12 employees agreed that people who retire from jobs in K-12 education are able to live comfortably in retirement- -- a decrease of six percentage points from March. Even fewer felt that their employer does a good job of preparing them for retirement (37% in March and 34% in October). Information for this report is derived from an October 2020 national survey of 1,205 state and local government employees, including 494 K-12 public school employees. The survey, conducted by SLGE at ICMA-RC and Greenwald Research, assessed public sector employee views on the impact of the pandemic on their employment and financial outlook, safety concerns, and employer and benefits satisfaction. When applicable, results are compared to a March 2020 survey of 400 K-12 employees. Final data for both surveys were weighted by gender, age, income, and industry type to reflect the distribution of the state and local government workforce as found in the U.S. Census Bureau’s Current Population Survey and the U.S. Census of Governments. The Center for State and Local Government Excellence at ICMA-RC The Center for State and Local Government Excellence (SLGE) was founded in 2007 by ICMA-RC, and in 2021, the two organizations formally joined forces to form the Center for State and Local Government Excellence at ICMA-RC. SLGE helps local and state governments become knowledgeable and competitive employers so they can attract and retain a talented and committed workforce. It identifies leading practices and conducts research on public retirement plans, health and wellness benefits, workforce demographics and skill set needs, labor force development, as well as topics facing the not-for-profit industry and the education sector. Additionally, the center brings state and local leaders together with respected researchers. For more information, access to all research and publications, and to sign up for the center’s newsletter, visit slge.org and follow @4GovtExcellence on Twitter. CONTACT: Aprile Pritchet ICMA-RC 202-962-8067 firstname.lastname@example.org Kelly Kenneally State and Local Government Excellence at ICMA-RC 202-256-1445 email@example.com
The Board of Trustees of The Gabelli Global Utility & Income Trust (NYSE American: GLU) (the "Fund") approved the continuation of its policy of paying fixed monthly cash distributions. The Board of Trustees declared cash distributions of $0.10 per share for each of April, May, and June 2021.
TORONTO — The loonie topped 80 cents US, while Canada's main stock index edged higher in early trading and U.S. stock markets moved lower. The Canadian dollar traded for 80.11 cents US compared with 79.69 cents US on Wednesday. The rise in the currency came as the S&P/TSX composite index was up 16.37 points at 18,500.90. In New York, the Dow Jones industrial average was down 4.31 points at 31,957.55. The S&P 500 index was down 2.62 points at 3,922.81, while the Nasdaq composite was down 10.32 points at 13,587.65. The April crude oil contract was down 25 cents at US$62.97 per barrel and the April natural gas contract was down a penny at US$2.79 per mmBTU. The April gold contract was down US$18.90 at US$1,779.00 an ounce and the May copper contract was up two cents at US$4.33 a pound. This report by The Canadian Press was first published Feb. 25, 2021. Companies in this story: (TSX:GSPTSE, TSX:CADUSD=X) The Canadian Press
Around one in ten rail services should be cut while passenger numbers remain low, says Network Rail.
Planning permission was granted for the 52,888-capacity ground near the River Mersey, which is scheduled to open in time for the 2024-25 season.
Acne Drugs Market Research Report by Acne Type (Comedonal, Cystic, Inflammatory, and Postsurgical/Wound), by Drug Class (Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids), by Drug Type, by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Acne Drugs Market Research Report by Acne Type, by Drug Class, by Drug Type, by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06027986/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Acne Drugs Market is expected to grow from USD 5,123.97 Million in 2020 to USD 7,146.37 Million by the end of 2025.2. The Global Acne Drugs Market is expected to grow from EUR 4,492.79 Million in 2020 to EUR 6,266.07 Million by the end of 2025.3. The Global Acne Drugs Market is expected to grow from GBP 3,994.10 Million in 2020 to GBP 5,570.55 Million by the end of 2025.4. The Global Acne Drugs Market is expected to grow from JPY 546,857.44 Million in 2020 to JPY 762,698.76 Million by the end of 2025.5. The Global Acne Drugs Market is expected to grow from AUD 7,440.68 Million in 2020 to AUD 10,377.47 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Acne Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Acne Type, the Acne Drugs Market studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound. Based on Drug Class, the Acne Drugs Market studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids. Based on Drug Type, the Acne Drugs Market studied across OTC Drugs and Prescription Drugs. Based on Route of Administration, the Acne Drugs Market studied across Injectable, Oral, and Topical. Based on Geography, the Acne Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Acne Drugs Market including AbbVie Inc., Almirall, S.A., AndroScience Corporation, Anterios Inc, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc, Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd, F. Hoffmann-La Roche AG, Foamix Pharmaceuticals Ltd., Galderma S.A., Guthy-Renker LLC, Johnson & Johnson Services, Inc, Mayne Pharma Group Limited, Medicis Pharmaceutical Corporation, Mylan N.V, Oculus Innovative Sciences, Pfizer Inc., Ranbaxy Laboratories Limited, Skinvisible Pharmaceuticals, Stiefel Laboratories, Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceutical International Inc. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acne Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Acne Drugs Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acne Drugs Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acne Drugs Market?4. What is the competitive strategic window for opportunities in the Global Acne Drugs Market?5. What are the technology trends and regulatory frameworks in the Global Acne Drugs Market?6. What are the modes and strategic moves considered suitable for entering the Global Acne Drugs Market?Read the full report: https://www.reportlinker.com/p06027986/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
In accordance with article 19 of Regulation (EU) No. 596/2014, Solar is required to report trading with Solar A/S shares and related financial instruments carried out by members of the Board of Directors, members of the Executive Board and related parties. In 2017, the Board of Directors granted share options to the Executive Board and management team, and a number of these employees now exercise their respective share options. At the time of granting in 2017, the exercise price was fixed at DKK 373.84. The settlement price in 2021 is determined at DKK 456.39. Solar announces the transactions below under ID code DK0010274844 Solar B based on the reports received by Solar. All transactions relate to the exercise of share options from the grant year 2017 and will either be converted into shares or settled with cash. CEO Jens E. Andersen has exercised 2,709 share options, and is thereby granted an equivalent number of shares. CFO Michael H. Jeppesen has exercised 2,186 share options, and is thereby granted an equivalent number of shares.CCO Hugo Dorph has exercised 2,703 share options, equating a total cash settlement of DKK 223,140. Solar has no further outstanding share options. For the purpose of these transactions, Solar has sold 4,895 B shares. Solar’s portfolio of treasury shares now totals 56,813 B shares. Contacts Chairman of the Board of Directors Jens Borum Tel. +45 79 30 00 00 IR Director, Dennis Callesen - Tel. +45 29 92 18 11 Attachment No. 6 2021 Exercise of share options
The showman sold millions of records throughout his long career.
The "Baby Wipes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The 20-time Grand Slam winner has been struggling with a back issue since the build-up to the Australian Open and was forced to skip Spain's ATP Cup ties earlier this month. "Unfortunately, Rafael Nadal is forced to pull out of the 48th ABN AMRO World Tennis Tournament," the tournament organisers said in a statement. Despite the injury, Nadal did not drop a single set at the Australian Open until the quarter-final stage, where he was knocked out by Greek Stefanos Tsitsipas last week.
MATTOON, Ill. (AP) _ Consolidated Communications Holdings Inc. (CNSL) on Thursday reported a loss of $6.9 million in its fourth quarter. On a per-share basis, the Mattoon, Illinois-based company said it had a loss of 9 cents. Earnings, adjusted to extinguish debt and for stock option expense, came to 12 cents per share.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce that Big Pharma Split Corp. (the “Company”) has completed the overnight marketing of 385,200 Preferred Shares and 385,200 Class A Shares of the Company for gross proceeds of $9,341,100. The offering is being led by BMO Capital Markets, CIBC World Markets Inc. and Scotia Capital Inc. The sales period of the overnight offering has now ended. The offering is expected to close on or about March 4, 2021 and is subject to certain closing conditions including approval by the Toronto Stock Exchange. The Preferred Shares were offered at a price of $10.50 per Preferred Share to yield 4.8% and the Class A Shares were offered at a price of $13.75 per Class A Share to yield 9.0%. The closing price on the TSX of each of the Preferred Shares and the Class A Shares on February 24, 2021 was $10.52 and $13.99, respectively. The net proceeds of the offering will be used to invest in an equally-weighted portfolio of ten issuers comprised of equity securities selected by Harvest from a universe of pharmaceutical issuers which includes: Eli Lilly and Company | Johnson & Johnson | Amgen Inc. | Novartis AG | Pfizer Inc. AstraZeneca PLC | Sanofi SA | Merck & Co Inc. | Bristol-Myers Squibb Company | AbbVie Inc. In order to seek to generate additional returns, Harvest may write call options each month in respect of some or all of the equity securities in the portfolio. The investment objectives for the Preferred Shares are to provide their holders with fixed cumulative preferential quarterly cash distributions in the amount of $0.125 per Preferred Share ($0.50 per annum) until December 31, 2022 (the “Maturity Date”) and to return of the original issue price to holders on the Maturity Date. The investment objectives for the Class A Shares are to provide their holders with regular monthly cash distributions targeted to be $0.1031 per Class A Share ($1.2372 per annum) and with the opportunity for growth in net asset value per Class A Share. Harvest is the manager, portfolio manager and promoter of the Company. For additional information: Please visit www.harvestportfolios.com, e-mail email@example.com or call toll free 1-866-998-8298. About Harvest Portfolios Group Inc. Founded in 2009, Harvest is a Canadian Investment Fund Manager managing over $1.2 billion in assets for Canadian Investors. Harvest offers an innovative suite of exchange traded funds, mutual funds and publicly-listed structured fund products designed to satisfy the long-term growth and income needs of investors. We pride ourselves in creating trusted investment solutions that meet the expectations of our investors. A prospectus supplement to the Company’s short form base shelf prospectus dated November 4, 2020 containing important detailed information about the Preferred Shares and the Class A Shares being offered will be filed with the securities commissions or similar authorities in each of the provinces and territories of Canada. Copies of the prospectus supplement and the short form base shelf prospectus may be obtained from your registered financial advisor using the contact information for such advisor, or from representatives of the agents listed above. There will not be any sale or any acceptance of an offer to buy the securities being offered until the prospectus supplement has been filed with the Securities Commissions or similar authorities in each of the provinces and territories of Canada.